Why are tubulins different?
Andrea Ciliberto, PhD
IFOM – Istituto Fondazione di Oncologia Molecolare ETS
When: 12.00-1 pm, Wednesday, October 23st 2024
Where: Aula Falaschi, Ground floor, Institute of Molecular Genetics Via Abbiategrasso 207, Pavia
(Entrance in Via Ferrata 9, Campus “La Nave”, University of Pavia
Individual G-quadruplex targeting with chemically functionalised CRISPR-Cas9 uncovers ligand-specific biological responses
Marco di Antonio, PhD
Imperial College London, Department of Chemistry, London, UK
When: 12.00-1 pm, Monday, October 21st 2024
Where: Aula Falaschi, Ground floor, Institute of Molecular Genetics Via Abbiategrasso 207, Pavia
(Entrance in Via Ferrata 9, Campus “La Nave”, University of Pavia)
IGM colleagues remember Sammy Basso, a brilliant researcher, a friend, a guide in our work.
Sammy had a love of life and was always friendly, ironic and cheerful. We will continue studying progeria with Sammy’s enthusiasm, being even more motivated by the influence he had on each of us . Thank you Sammy!
Wednesday, March 6th, 2024, at 3 pm (CET),
Dr. Jeremy C. Borniger
Assistant Professor at Cold spring Harbour Laboratory (US)
will be presenting a seminar titled:“Neuronal circuit basis for glucocorticoid circadian rhythm disruption in breast cancer”To join the seminar, please use the following Teams link:https://teams.microsoft.com/l/meetup-join/19%3ameeting_MDQxNWQyZjUtNzNkNS00NGJlLThlMTMtYzVjMWJjNTVmN2Q5%40thread.v2/0?context=%7b%22Tid%22%3a%2234c64e9f-d27f-4edd-a1f0-1397f0c84f94%22%2c%22Oid%22%3a%221503aa2f-fb68-4453-8463-7eedfff33201%22%7d
CNR-IGM, Istituto di Genetica Molecolare “Luigi Luca Cavalli Sforza” is proud to announce that Sara Tavella was awarded with the DSB 2023 Scientific Prize for the research topic entitled: “Molecular, cellular, immunological and epidemiological aspects of the #SARS-#CoV2 #infection”.
A virtual forum organized by GiiN
Winter Spring 2024 – Seminars Calendar:
From 5 to 6PM Rome, ZOOM link: https://uniroma1.zoom.us/j/95149984403
For more information contact or visit:
Twitter: GenomeIINetwork
GenomeIntegrityItaly@gmail.com
https://genomeintegrityita.wixsite.com/giin
A possible therapeutic solution for treating ALT tumors has been identified in the IFOM laboratories, which include for example glioblastoma and osteosarcoma and against which chemotherapy and radiotherapy are not very effective. It is a therapy based on Antisense Oligonucleotides that acts on RNAs that promote the longevity of cancer cells of this type of tumor. The study, recently published in Nature Communications, was supported by the AIRC Foundation.
Ilaria Rosso, Corey Jones-Weinert, Francesca Rossiello, Matteo Cabrini, Silvia Brambillasca, Leonel Munoz-Sagredo, Zeno Lavagnino, Emanuele Martini, Enzo Tedone, Massimiliano Garre’, Julio Aguado, Dario Parazzoli, Marina Mione, Jerry W. Shay, Ciro Mercurio & Fabrizio d’Adda di Fagagna
Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs
Nat Commun. 2023 Nov 4;14(1):7086. doi: 10.1038/s41467-023-42831-0